BCL2L1 Antikörper
-
- Target Alle BCL2L1 Antikörper anzeigen
- BCL2L1 (BCL2-Like 1 (BCL2L1))
-
Reaktivität
- Human
-
Wirt
- Kaninchen
-
Klonalität
- Monoklonal
-
Konjugat
- Dieser BCL2L1 Antikörper ist unkonjugiert
-
Applikation
- Western Blotting (WB), Immunohistochemistry (IHC), Flow Cytometry (FACS), Immunoprecipitation (IP)
- Kreuzreaktivität
- Human, Affe, Maus, Ratte (Rattus)
- Kreuzreaktivität (Details)
- Calculated cross reactivity: Hu Mk Mo Rt
- Produktmerkmale
- Bcl-XL
- Aufreinigung
- Purified
- Immunogen
- Synthetic peptide (KLH-coupled) corresponding to residues surrounding Asp61 of human Bcl-xL.
- Klon
- 5i116
- Top Product
- Discover our top product BCL2L1 Primärantikörper
-
anti-BCL2-Like 1 (BCL2L1) (AA 1-233) antibody
BCL2L1 Reaktivität: Human WB, ELISA, IF, PLA Wirt: Maus Monoclonal 3E2-2A5 unconjugated
anti-BCL2-Like 1 (BCL2L1) antibodyBCL2L1 Reaktivität: Human WB, IF, IP, IHC (p), ICC Wirt: Kaninchen Polyclonal unconjugated
anti-BCL2-Like 1 (BCL2L1) (AA 1-120) antibodyBCL2L1 Reaktivität: Human WB, IHC, IF, IP Wirt: Kaninchen Polyclonal unconjugated
anti-BCL2-Like 1 (BCL2L1) (AA 2-212) antibodyBCL2L1 Reaktivität: Human WB, IHC, IP, ICC Wirt: Kaninchen Polyclonal unconjugated
anti-BCL2-Like 1 (BCL2L1) (AA 2-212) antibodyBCL2L1 Reaktivität: Ratte WB, IHC, IP, ICC Wirt: Kaninchen Polyclonal unconjugated
anti-BCL2-Like 1 (BCL2L1) (AA 2-212) antibodyBCL2L1 Reaktivität: Ratte WB, IHC, IP, ICC Wirt: Maus Monoclonal C2 unconjugated
anti-BCL2-Like 1 (BCL2L1) (AA 1-233) antibodyBCL2L1 Reaktivität: Human WB, IF, PLA Wirt: Kaninchen Polyclonal unconjugated
anti-BCL2-Like 1 (BCL2L1) (AA 1-209) antibodyBCL2L1 Reaktivität: Human WB, IHC, ELISA, IF Wirt: Kaninchen Polyclonal unconjugated
anti-BCL2-Like 1 (BCL2L1) (AA 81-200) antibodyBCL2L1 Reaktivität: Human, Maus, Ratte, Schwein, Schaf WB, ELISA, FACS, IHC (p), ICC, IF (cc), IF (p), IHC (fro) Wirt: Kaninchen Polyclonal unconjugated
anti-BCL2-Like 1 (BCL2L1) (pSer62) antibodyBCL2L1 Reaktivität: Human WB, IHC, ELISA, IF Wirt: Kaninchen Polyclonal unconjugated
-
- Applikationshinweise
- Optimal working conditions should be determined by the investigator.
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Buffer
- Supplied as a liquid in 10 mM sodium HEPES, pH 7.5, 150 mM NaCl, 100 μg/mL BSA, 50 % glycerol.
- Lagerung
- -20 °C
- Informationen zur Lagerung
- -20°C
-
- Target
- BCL2L1 (BCL2-Like 1 (BCL2L1))
- Andere Bezeichnung
- Bcl-XL (BCL2L1 Produkte)
- Pathways
- Apoptose, Negative Regulation of intrinsic apoptotic Signaling
-
